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0 Short bowel syndrome (SBS) in the newborn results in 
limited intestinal absorptive capacity, leading especially to 
fatty acid (FA) malabsorption. It is unknown whether adapta- 
tion occurs in time in FA absorption, and whether this 
adaptation is chain-length dependent. The aim of the present 
study was to prospectively evaluate FA absorption and 
excretion during SBS in the newborn. Twenty-one neonates 
who underwent small bowel resection (of variable length) for 
various reasons (necrotizing enterocolitis, intestinal atresia, 
meconium peritonitis, cloaca1 extrophy, etc) were studied. 
Eight neonates had SBS, defined as a small bowel remnant of 
less than 50% of the original small bowel length related to 
gestational age. The mean remaining small bowel length in 
the SBS group was 34% (24% to 42%). The non-SBS control 
group consisted of 13 neonates who had only minor small 
bowel resections. The mean remaining bowel length for the 
non-SBS group was 95% (70% to 100%). The results show 
that the total fractional excretion of FA (FE-FA) at 2 weeks 
and 1, 2, 3, and 4 months postsurgery was 51% & 37%. 
33% f 24%, 51% f 65%, 53% 2 27%, and 7% + 2% in 
patients with SBS, versus 12% f 6%, 24% + lo%, 9% f 3%. 
8% + 3% and 17% + 14% in the non-SBS controls, respec- 
tively (P c .05 by ANOVA). There appeared to be an ameliora- 
tion in time in FA absorption, especially in the SBS group, 
after 3 months. FE-FA was chain-length related, being consid- 
erably less for Cl0 and Cl2 than for Cl4 and longer amounts. 
An amelioration of absorption occurred in the SBS patients, 
especially with the longer-chain FA. On the basis of the study 
data, the authors conclude that in the initial adaptation 
phase shorter chain lengths are better absorbed than longer 
chain lengths; however, in the latter FA group, substantial 
adaptation occurs with time. 
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S HORT BOWEL SYNDROME (SBS) occurring after massive intestinal resection is character- 
ized by severe diarrhea, malabsorption, negative nitro- 
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gen balance, and body weight loss, primarily as a 
. result of a drastic decrease in intestinal absorptive 
surface.‘s2 The adaptive response in the remaining 
small and large intestine is marked by hyperplastic 
villi, with parallel increases in segmental mucosal 
DNA, RNA, protein, and weight.3-6 Mucosal adapta- 
tion ultimately results in diminution of malabsorptive 
nutritional losses.2%7 The intestinal adaptation is 
achieved by the interaction of various factors for 
which the presence of enteral substrate is very impor- 
tant.8,9 Because the outcome after major bowel resec- 
tion in the neonatal period depends primarily on the 
time needed for adaptation of the bowel,lO it is of 
utmost importance to achieve enteral autonomy as 
soon as possible. Depending on the composition of 
the luminal content, mucosal growth can be en- 
hanced.“-l5 
Of the individual dietary components, it has been 
suggested that long-chain triglycerides (LCT) may be 
especially potent promoters of small intestinal muco- 
sal cell proliferation. 14,16-18 However, because fat mal- 
absorption is common in these patients,19,20 supplying 
medium-chain triglycerides (MCT) instead of LCT is 
a standard practice. The reason for this is that MCT 
are hydrolysed more rapidly by pancreatic lipase than 
are LCT21 and are transported principally by the 
portal vein to the liver for oxidation rather than 
through the intestinal lymphatic vessels, which are 
used by LCT.22 
Because little is known about the adaptation that 
occurs with time in MCT- and LCT-derived fatty acid 
(FA) malabsorption and about whether this malab- 
sorption/adaptation is chain-length dependent, we 
conducted a prospective study that evaluates FA 
absorption and excretion in neonates with SBS and 
neonates who underwent minor small bowel resec- 
tion. 
MATERIALS AND METHODS 
Patients 
Twenty-one neonates had undergone intestinal resection, of 
variable length, as a consequence of various underlying diseases. 
The diagnoses were necrotizing enterocolitis (NEC),‘O jejunal 
atresia (3), meconium peritonitis (non-cystic fibrosis) (3), cloaca1 
extrophy (2), Hirschsprung’s disease (1) multiple atresia (1) and 
obstruction ileus (non-cystic fibrosis) (1). Fifteen patients were 
born prematurely (before 37 weeks’ gestation). 
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The patients were divided into two groups. Eight had SBS (SBS 
group), defined as a loss of more than 50% of the original small 
bowel as related to gestational age.23 The mean remaining small 
bowel length related to gestational age in this group was 34% 
(range, 24% to 42%). Thirteen patients had only minor small bowel 
resections (non-SBS group), and served as controls. Their mean 
remaining small bowel length related to gestational age averaged 
95% (range, 70% to 100%). 
In the SBS group (n = 8), five patients had an ileostomy; in the 
non-S&IS group (n = 13) nine patients had an ileostomy and one 
had a colostomy. As reported earlier, 24 the intestinal continuity in 
these groups of patients was reestablished after an average of 
approximately 100 days after the initial operation. Growth was 
recorded regularly. Patient data are summarized in Table 1. 
FA Intake, Excretion, and Analysis 
The patients participated in a prospective evaluation of nutri- 
tional intake of FA and faecal excretion of FA. The protocol was 
begun after 2 weeks of recovery and stabilization of the patient and 
after informed consent was obtained from the parents or caretak- 
ers. During a 72.hour period, enterostomy fluid or faeces were 
collected for analysis at week 2 and 1, 2, and 3 months postopera- 
tively, and subsequently one-time 24-hour faeces were collected at 
4,6, and 12 months postoperatively. FA intake was calculated from 
the amount of food intake of a specific formula and the FA content 
of that formula. FA excretion was calculated from enterostomy 
fluid or faecal collections and from the FA concentrations. For FA 
analysis, the total stool sample was homogenized and the volume 
determined. Then, a representative sample was taken, which was 
analyzed by use of gas chromatography.25 Intake and excretion of 
FA were calculated in food and faeces (respectively) for the total of 
all FA and for chain lengths ClO, C12, C14, C16, and C18. The 
fractional excretion was calculated as: 
FA output 
100 x ___ 
FA input 
as a measure of the FA malabsorption of the gut. 
Statistical Analysis 
Data are presented as mean 2 SEM. P values of less than .05 
were considered significant. Statistical analyses were performed 
with the SPSS/PC+ statistical software package on a standard 
personal computer.26 For analysis of the main effects of group and 
time as well as their interactions, analysis of variance (ANOVA) 
was used. For time effects within groups, the one-way ANOVA was 
used. Both ANOVA procedures were run for the entire study 
Table 1. Characteristics of Patients 
SBS NON-SBS 
No. of patients 8 13 
Mean gestational 35.2 (range, 28 to 40) 33.7 (range, 29 to 42) 
age (wk) 
Male:female ratio 5:3 8:5 
Enterostomy 5 lleostomy 9 lleostomy 
1 Colostomy 
Mean weight at start of 2,610 f 480 2,500 e 380 
protocol (g) 
Mean weight at age 3,950 * 490 4,500 k 280 
4 mo (9) 
Mean remaining small 34 (range, 24 to 42) 95 (range, 70 to 100) 
bowel lensth (%) 
Table 2. Faecal Fatty Acid Excretion in SBS and Non-SBS Patients 
No. of Months After Sumerv 
1% 1 2 3 4 6 12 
FE TOT 
SBS 
CON 
FECIO 
SBS 
CON 
FE Cl2 
SBS 
CON 
FE Cl4 
SBS 
51 2 37 33 !I 24 51 z!z 65 53 k 27 7k2 320 5 
1228 24 5: 10 9*3 823 17-tl4 2 
925 8 5: 4 5k8 15 f 14 1+-l 2&l 1 
1+1 9 2, 7 Ok0 l&l 5-t5 0 
IO t 4 17 2: 18 51 
11 t 11 9 5: 8 32 
53 i 75 72 
17 XL 17 27 i: 5 
75 
8 
242 14 2kl 020 1 
l&l 10 k 10 
49 823 2kO 6 
9+6 12k9 2 
FE Cl6 
SBS 77250 443~24 61+63 87246 1624 5kl 14 
CON 19klO 383~15 69+67 18~10 24k14 6 
FE Cl8 
SBS 60 +37 41 t 24 58,69 82 2 47 82 3 3 20 2 
CON 17 + 10 37 + 17 522 7?2 18k15 1 
NOTE. Ifthe numbercfdeterminations is lessthan 3, no SEM is given. 
Abbreviations: SBS, patients with short bowel syndrome; CON, 
patients with non-shorrt bowel syndrome; FE TOT, faecal fractional 
excretion of total of all fatty acids; FE ClO, C12, C14, C16, and Cl& 
faecal fractional excretion of fatty acids with (respectively) 10, 12, 14, 
16, and 18 carbon atoms,. 
period as well as for various shorter intervals. For clarity, only the 
results of the total study period and the time span between 2 weeks 
and 3 months postsurgery will be discussed. Differences between 
groups at individual time points were tested nonparametrically 
using the Mann Whitney U test. (Because the latter test did not 
yield additional valuable information, it will not be discussed 
further.) 
RESULTS 
Patient characteristics are summarized in Table 1. 
The SBS and non-SBS groups are comparable with 
the exception of the mean remaining bowel length, 
which was 34% (24% to 42%) and 95% (70% to 
100%) respectively. 
In Table 2, the fractional faecal FA excretion in 
SBS and non-SBS patients is shown. Data are pre- 
sented as mean 2 SEM. The results show that total 
FA fractional excretion at 2 weeks and 1, 2, 3 and 4 
months postsurgery was 51% ? 37%, 33% & 24%, 
51% t 65%, 53% & 27%, and 7% _t 2% in SBS 
patients and 12% ? 8%, 24% +- lo%, 9% -+ 3%, 
8% 2 3%, and 17% ? 14% in non-SBS controls, 
respectively. Statistical analysis (ANOVA) for the 
period between 2 weeks and 3 months postsurgery 
showed a significant difference between the curves 
(Fig 1). 
With respect to the fractional faecal FA excretion 
of the individual chain lengths, the following results 
were obtained. For Cl0 and Cl2 FA, the fractional 
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Fig 1. Fractional faecal fatty acid excretion for the total of all fatty 
acids in patients tiith short bowel syndrome (n = 8; bowel remnant 
length, 34% rf 3%; dots) compared with patients operated on for 
sirhilar conditions but with near-normal gut remnant (n = i3; gut 
remnant length, 95% 2 4%; triangles). Statistical significance (P e .05; 
ANOVA analysis between 2 weeks and 3 months) is indicated by the 
asterisks. 
-t- SBS --A-- NO SBS 
Fig 2. Fractional faecal fatty acid excretion for Cl0 chain length 
fatty acids in patients with short bowel syndrome (n = 8; bowel 
remnant length, 34% f 3%; solid circles] compared with patients 
operated on for similar conditions but with near-normal gut remnant 
(n = 13; gut remnant length, 95% f 4%; triangles). There were no 
significant differences. 
faecal excretion did not differ significantly for the two 
patient groups, and ranged, at the observed time 
points, between 1% ? 1% and 24% f 14%, with a 
few exceptionally high values. In neither the Cl0 nor 
the Cl2 group of FA was there a significant difference 
between the curves (ANOVA analysis for the period 
between 2 weeks and 3 months as well as for all other 
time ranges). For the Cl0 FA, this is depicted in Fig 
2. For the C14, C16, and Cl8 FA, the fractional faecal 
excretion ranged from 40% to more than 80% in the 
SBS group, and was significantly higher (ANOVA 
analysis) in SBS patients in the first 3 months postsur- 
gery. The values from 4 months postsurgery onward 
did not differ significantly. The curves of Cl4 and Cl8 
fractional faecal FA excretion are shown in Figs 3 
and 4. 
the absorption in SBS neonates, between FA of up to 
12 carbon atoms (MCT) and FA of 14 or more carbon 
atoms (LCT). The results confirm those of animal 
studies in which the absorption of dietary fat contain- 
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DISCUSSION 0 
In the present study we found that FA absorption 
(as assessed by the measurement of fractional FA 
excretion in stools) in neonates with SBS is. depen- 
dent on FA chain length and on the time between 
evaluation and initial small bowel resection. The 
shorter chain lengths, especially Cl0 and C12, are 
absorbed almost completely from the time enteral 
nutrition is begun. The longer chain lengths are 
malabsorped for at least 12 weeks after surgery. From 
our data it appears that there is a separation point in 
Fig 3. Fractional faecal fatty acid excretion for Cl4 chain length 
fatty acids in patients with short bowel syndrome (n = 8; bowel 
remnant length, 34% ir 3%; dots) compared with patients operated 
on for similar conditions but with near-normal gut remnant (n = 13; 
gut remnant length, 95% ? 4%; triangles). Statistical significance 
(P c .05; ANOVA analysis between 2 weeks and 3 months) is indi- 
cated by the asterisks. 
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Fig 4. Fractional faecal fatty acid excretion for Cl8 chain length 
fatty acids in patients with short bowel syndrome (n = 8; bowel 
remnant length, 34% + 3%. dots) compared with patients operated 
on for similar conditions but with near-normal gut remnant (n = 13; 
gut remnant length, 95% f 4%; triangles). Statistical significance 
(f c .05; ANOVA analysis between 2 weeks and 3 months) is indi- 
cated by the asterisks. 
ing LCT and MCT was evaluated and it was shown 
that MCT are more rapidly hydrolysed and absorbed 
in the intestinal lumen than are LCT.22 The proximal 
small bowel being the preferred side of MCT absorp- 
tion and the mid and distal small bowel being the 
preferred side of LCT absorption might explain why 
there is a difference in fractional faecal FA excretion 
between the SBS and non-SBS groups. 
Although the advantage of MCT from the stand- 
point of rate of absorption in SBS has been well 
documented,21,27 little is known about the effect of the 
remaining colon on FA (mal)absorption and about 
the effect of LCTversus MCT on mucosal adaptation. 
In the present study there appeared to be a rapid 
decrease in the malabsorption of Cl4 and longer FA 
chains, and thus enhanced adaptation between 3 and 
4 months postsurgery. This coincides with the closure 
of enterostomies around this time.24 The sudden 
amelioration in the absorption of the longer FA after 
3 months might be attributable true adaptation in the 
small bowel remnant in the SBS group. Alternatively, 
this might be related to the inclusion of the colon in 
the intestinal stream after closure of enterostomies, 
with or without a terminal ileal segment and the 
ileocoecal valve. Regardless of this adaptation or its 
explanation, the data provide evidence that it might 
be better to give MCTs instead of LCTs during the 
first 3 months after resection. 
523 
Morin et all4 reported that, in rats, morphological 
mucosal hyperplasia (as determined by measurement 
of mucosal protein and DNA content) was greater 
after LCT feedings than after to MCT feedings. 
Vanderhoof et all3 confirmed these results in rats and 
added the observation that mucosal function im- 
proved after the use of LCT feedings, as demon- 
strated by enhanced leucine uptake in the distal small 
bowel and enhanced sucrase activity in the proximal 
small bowel in the: animals subjected to small bowel 
resection. To clarify the relative enterotrophic ac- 
tions of different triglycerides, Jenkins and Thomp- 
son28 gave rats five different oils in mixed diets and 
compared the effelcts on the overall mass of the small 
intestine and on the distribution of mass along the 
small intestine. Subsequently, the enterotrophic ‘ef- 
fects of bolus doses of LCT and MCT were compared. 
They found that LCT and MCT differed in their 
regional effects on cell proliferation; all four LCT- 
rich diets increased mucosal mass and cell prolifera- 
tion maximally in the mid small intestine, whereas 
MCT diets had thle greatest effect proximally. When 
the LCT and MCT diets were given as boluses, the 
differences disappeared. The authors suggested that 
the enterotrophic effect of bolus MCT is the result of 
accelerated transit causing the release in the distal 
small bowel of am enterotrophic peptide that en- 
hanced the overall trophic effect to the small bowel. It 
is noteworthy that the infusion of MCT directly into 
the human ileum causes a release of enterogluca- 
gon,29 which has been proposed as an enterotrophic 
hormone.30 
In summary, it is possible that LCT-rich diets have 
a positive effect ‘on adaptation after small bowel 
resection. However, the issue is whether this positive 
LCT effect outweighs the physiological advantages of 
MCT. From our clinical data and the results of animal 
studies, it remains unclear which form of triglycerides 
(MCT or LCT) should be used in SBS patients. One 
animal study has addressed this question, comparing 
the relative effects of diet mixtures containing either 
50% MCT/SO% LCT or 100% LCT.31 It was shown 
that the diet that contained 50% MCT/SO% LCT led 
to a higher increase in the mucosal mass and protein 
content. It was found that the mixed diet determined 
the most appropriate lipid content and composition 
in the brush-border membrane.32 There were no 
deleterious effects of the mixed diet on the activities 
of sucrase, lactase, or aminopeptidase.33 
On the basis of our data and the literature cited, it 
is our opinion that the enteral diet of neonates with 
SBS should contain a mixture of MCT and LCT, to 
combine the physiological advantages of MCT with 
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the positive effects of LCT on adaptation and the 
maintenance of a sufficient supply of essential FAs 
(Cl8 provided by the LCT component). Otherwise, 
detrimental changes in intestinal morphology and 
membrane lipid composition could occur as a result 
of essential FA deficiency in the diet.34-36 Further- 
more, avoiding enterostomies certainly enhances re- 
habilitation. If no reanastomosis is performed, then it 
should be considered to reinfuse proximal enteros- 
tomy output in the distal enterostomy to include the 
remaining small bowel and colon in the adaptation 
process.35,36 
A prospective clinical trial that compares the ef- 
fects of a mixed MCTiLCT diet to those of an LCT 
diet in neonates with SBS is warranted. To enhance 
the enterotrophic effects, these diets should be given 
as a bolus.37 
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